Loading data
CRSRNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1.47 bn USD | 1.32 bn USD | 1.46 bn USD | 1.38 bn USD | 1.9 bn USD |
| Cost of revenue | 1.05 bn USD | 988.78 m USD | 1.1 bn USD | 1.08 bn USD | 1.39 bn USD |
| Gross profit | 425.88 m USD | 327.6 m USD | 360.26 m USD | 296.63 m USD | 513.85 m USD |
| Research and development expense | 69.15 m USD | 67.54 m USD | 65.26 m USD | 66.49 m USD | 60.29 m USD |
| Selling, general and administrative expense | 354.66 m USD | 310.01 m USD | 285.31 m USD | 284.93 m USD | 315.67 m USD |
| Operating profit | 2.08 m USD | -49.95 m USD | 9.69 m USD | -54.79 m USD | 137.89 m USD |
| Profit before tax | -12.15 m USD | -61.66 m USD | -3.48 m USD | -63.77 m USD | 114.56 m USD |
| Income tax expense | 2.82 m USD | 21.74 m USD | -2.44 m USD | -9.82 m USD | 13.6 m USD |
| Net income (reported basis) | -14.97 m USD | -83.39 m USD | -1.04 m USD | -53.95 m USD | 100.96 m USD |
| Net income attributable to common shareholders | -12.47 m USD | -99.18 m USD | 3.19 m USD | -60.92 m USD | 100.96 m USD |
| Basic earnings per share | -0.12 USD/share | -0.95 USD/share | 0.03 USD/share | -0.63 USD/share | 1.08 USD/share |
| Diluted earnings per share | -0.12 USD/share | -0.95 USD/share | 0.03 USD/share | -0.63 USD/share | 1.01 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.